The Costs to the US Health Care System of Extending Marketing Exclusivity for Taxol
1 September 1999
By Dr. Richard Rozek
This paper was published in the Journal of Research in Pharmaceutical Economics, Vol. 9, September 1999: 21-41.
A reprint of this article is available from the author upon request.
